Zhang, A. Y., Cardaci, G., Singh, A., Gurney, H., Srinivas, S. M., Macaraeg, A., Wong, J. Y., Dorff, T. B., Song, H., Srinivas, S., Dreicer, R., Ürün, Y., Kucuk, O., Yang, Z., Du, P., Robert, A., Ferreira, D. V., Barton, D., Ngai, S., Hansen, A. R. (2026). ProTACT: Preliminary data from a first-in-human, phase 1 study evaluating the safety, tolerability, and anti-tumor activity of [
                    <sup>225</sup>
                    Ac]Ac-FL-020, a PSMA-targeted radioconjugate, in patients with mCRPC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5050